News

Alzheimer’s Researchers Discover Bryostatin Can Slow, Reverse Disease Progression

Researchers from the Blanchette Rockefeller Neuroscience Institute (BRNI) have gathered evidence of the possible role of protein kinase C epsilon (PKCe) in the treatment of Alzheimer’s disease (AD). The news was recently announced by Neurotrope, a pharmaceutical company collaborating with BRNI in the development of bryostatin, a potent modulator of PKCe,…

National Plans Announced to Study FTD Along with Alzheimer’s Disease

Individuals with frontotemporal degeneration (FTD) may soon benefit from research priorities directed toward curing Alzheimer’s disease and other forms of dementia. The Association of Frontotemporal Degeneration (AFTD) broke word of plans to formally include FTD in national research priorities by the year 2025. According to AFTD Executive Director Susan…

Chance Discovery Of Normal Cognition In Patient Without Apolipoprotein E Could Point To New Alzheimer Treatments

A new free access paper published online before print in the journal JAMA Neurology, entitled, “Effects of the Absence of Apolipoprotein E on Lipoproteins, Neurocognitive Function, and Retinal Function” (JAMA Neurol. Published online August 11, 2014. DOI: 10.1001/.jamaneurol.2014.2011) documents a 40-year-old African American man referred…

Low Vitamin D Increases Risk for Alzheimer’s Disease

Vitamin D, known as the sunshine vitamin due to its mechanism of production in the body, is usually associated with calcium absorption and bone health, but researchers are finding that vitamin D is strongly linked to the risk for Alzheimer’s disease and dementia. Dr. David Llewellyn, from the University…

Free Online Memory Test Evaluates Brain Health Status in Persons Over 50

Increasing incidence of Alzheimer’s Disease and other forms of senile dementia as the population demographic ages has raised general anxiety levels. It’s not entirely paranoia. Risk of developing Alzheimer’s doubles every five years after age 65. Toronto, Canada-based Cogniciti, Inc. cites a recent Brain Health Study (about which more…

Aduhelm Approved